High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia

被引:13
|
作者
Haring, Martijn P. D. [1 ]
Peeks, Fabian [2 ]
Oosterveer, Maaike H. [3 ]
Brouwers, Martijn C. G. J. [4 ]
Hollak, Carla E. M. [5 ]
Janssen, Mirian C. H. [6 ]
Langendonk, Janneke G. [7 ]
Rennings, Alexander J. M. [6 ]
Wagenmakers, Margreet A. E. M. [7 ]
Verkade, Henkjan J. [8 ]
Derks, Terry G. J. [2 ]
de Meijer, Vincent E. [1 ,9 ,10 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Metab Dis, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Groningen, Netherlands
[4] Maastricht Univ Med Ctr, Dept Internal Med, Div Endocrinol & Metab Dis, Maastricht, Netherlands
[5] Amsterdam Univ Med Ctr, Univ Amsterdam, Dept Endocrinol & Metab, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[7] Erasmus MC, Univ Med Ctr Rotterdam, Ctr Lysosomal & Metab Dis, Dept Internal Med, Rotterdam, Netherlands
[8] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat,Pediat Gastroenterol & Hepatol, Groningen, Netherlands
[9] Univ Groningen, Hanzepl 1, NL-9700 RB Groningen, Netherlands
[10] Univ Med Ctr Groningen, Hanzepl 1, NL-9700 RB Groningen, Netherlands
基金
荷兰研究理事会;
关键词
Benign neoplasm; Hepatic adenoma; Glycogen storage disease type Ia; Metabolic disorder; Glucose-6-phosphatase triglycerides; FATTY-ACID SYNTHASE; MUTATION ANALYSIS; MANAGEMENT; CLASSIFICATION; GUIDELINES; CARCINOMA; DIAGNOSIS; RISK; GENE; 1A;
D O I
10.1016/j.jhepr.2022.100512
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Glycogen storage disease type Ia (GSDIa) is an inborn error of carbohydrate metabolism caused by pathogenic variants in the glucose-6-phosphatase catalytic subunit 1 (G6PC1) gene and is associated with hepatocellular adenoma (HCA) formation. Data on risk factors for HCA occurrence in GSDIa are scarce. We investigated HCA development in relation to sex, G6PC1 genotype, and serum triglyceride concentration (TG).Methods: An observational study of patients with genetically confirmed GSDIa >-12 years was performed. Patients were categorised for sex; presence of 2, 1, or 0 predicted severe G6PC1 variant (PSV); and median TG during childhood (<12 years; stratified for above/below 5.65 mmol/L, i.e. 500 mg/dl).Results: Fifty-three patients (23 females) were included, of which 26 patients developed HCA at a median (IQR) age of 21 (17-25) years. At the age of 25 years, 48% of females and 30% of males had developed HCA (log-rank p = 0.045). Two-thirds of patients with GSDIa carried 2 PSVs, 20% carried 1, and 13% carried none. Neither the number of PSVs nor any specific G6PC1 variants were associated with HCA occurrence. Childhood TG was 3.4 (3.0-4.2) mmol/L in males vs. 5.6 (4.0-7.9) mmol/L in females (p = 0.026). Childhood TG >5.65 mmol/L was associated with HCA development at younger age, compared with patients with childhood TG <5.65 mmol/L (18 vs. 33 years; log-rank p = 0.001). Cox regression analysis including TG, sex, and TG-sex interaction correction revealed childhood TG >5.65 mmol/L as an independent risk factor for HCA development (hazard ratio [HR] 6.0; 95% CI 1.2-29.8; p = 0.028).onclusions: In patients with GSDIa, high childhood TG was associated with an increased risk of HCA, and earlier onset of HCA development, independent of sex-associated hypertriglyceridaemia, and G6PC1 genotype.Lay summary: Glycogen storage disease type Ia (GSDIa) is a rare, inherited metabolic disease that can be complicated by liver tumours (hepatocellular adenomas), which in turn may cause bleeding or progress to liver cancer. Risk factors associated with hepatocellular adenoma formation in patients with GSDIa are largely unknown. In our study, we found that high serum triglyceride concentrations during childhood, but not specific genetic variants, were associated with increased risk of he-patocellular adenoma diagnosis later in life.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:9
相关论文
共 30 条
  • [21] Glucose-6-phosphatase gene mutations in Taiwan Chinese patients with glycogen storage disease type Ia
    Chiang, SC
    Lee, YM
    Chang, MH
    Wang, TR
    Ko, TM
    Hwu, WL
    JOURNAL OF HUMAN GENETICS, 2000, 45 (04) : 197 - 199
  • [22] A case study of glycogen storage disease type Ia presenting with multiple hepatocellular adenomas: an analysis by gadolinium ethoxybenzyl-diethylenetriamine-pentaacetic acid magnetic resonance imaging
    Li, Xiaoming
    Jing, Hui
    Cheng, Lin
    Xia, Jie
    Wang, Jian
    Li, Qing
    Liu, Chen
    Cai, Ping
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2021, 11 (06) : 2785 - 2791
  • [23] Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral d-[6,6-2H2]-glucose
    Rossi, Alessandro
    Oosterveer, Maaike H.
    van Dijk, Theo H.
    Bleeker, Aycha
    Koehorst, Martijn
    Weinstein, David A.
    Bakker, Barbara M.
    Derks, Terry G. J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (02) : 389 - 401
  • [24] The rs2229611 (G6PC:c.*23 T > C) is associated with glycogen storage disease type Ia in Brazilian patients
    Pinheiro, Franciele Cabral
    Sperb-Ludwig, Fernanda
    Fagundes Verch, Juliana Maria
    dos Santos, Bruna Bento
    Moura de Souza, Carolina Fischinger
    Doederlein Schwartz, Ida Vanessa
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2020, 25
  • [25] Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia
    Ki, CS
    Han, SH
    Kim, HJ
    Lee, SG
    Kim, EJ
    Kim, JW
    Choe, YH
    Seo, JK
    Chang, YJ
    Park, JY
    CLINICAL GENETICS, 2004, 65 (06) : 487 - 489
  • [26] Increased scavenger receptor class B type I-mediated cellular cholesterol efflux and antioxidant capacity in the sera of glycogen storage disease type Ia patients
    Nguyen, Andrew D.
    Pan, Chi-Jiunn
    Weinstein, David A.
    Chou, Janice Y.
    MOLECULAR GENETICS AND METABOLISM, 2006, 89 (03) : 233 - 238
  • [27] Glycogen storage disease type Ia: Molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells
    Akanuma, J
    Nishigaki, T
    Fujii, K
    Matsubara, Y
    Inui, K
    Takahashi, K
    Kure, S
    Suzuki, Y
    Ohura, T
    Miyabayashi, S
    Ogawa, E
    Iinuma, K
    Okada, S
    Narisawa, K
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 91 (02): : 107 - 112
  • [28] Predominance of the c.648G &gt; T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia
    Kim, Yoo-Mi
    Choi, Jin-Ho
    Lee, Beom-Hee
    Kim, Gu-Hwan
    Kim, Kyung-Mo
    Yoo, Han-Wook
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [29] Long-term personalized high-protein, high-fat diet in pediatric patients with glycogen storage disease type IIIa: Evaluation of myopathy, metabolic control, physical activity, growth, and dietary compliance
    Ucar, Sema Kalkan
    Altinok, Yasemin Atik
    Mansuroglu, Yelda
    Canda, Ebru
    Yazici, Havva
    Celik, Merve Yoldas
    Erdem, Fehime
    Yanbolu, Ayse Yueksel
    Ulger, Zuelal
    Coker, Mahmut
    JOURNAL OF INHERITED METABOLIC DISEASE, 2024, 47 (05) : 1001 - 1017
  • [30] Development of a rapid simultaneous assay of two urinary tetrasaccharide metabolites using differential ion mobility and tandem mass spectrometry and its application to patients with glycogen storage disease (type Ib and II)
    Ren, Jianwei
    Ma, Yufang
    Ma, Mingsheng
    Ding, Juan
    Jiang, Jingjing
    Zheng, Xin
    Han, Xiaohong
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2023, 415 (27) : 6863 - 6871